en · de · es · fr · pt
selank-notes.peptides9002.com › Blog › Mechanism And Evidence Status — Explained

Mechanism And Evidence Status — Explained

By Editorial Desk · published 2026-06-21 · last reviewed 2026-07-30 · Blog

Pro-Gly-Pro raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

Reviewed 2026-07-30. Anything still debated is marked as such rather than presented as settled.

Mechanism and Evidence Status

Pharmacokinetic data are sparse and largely derived from animal work. After intranasal administration the peptide appears in plasma within minutes, and reported half-lives are short, on the order of minutes to tens of minutes. Degradation proceeds through ordinary proteolytic cleavage into constituent amino acids and smaller fragments. Direct evidence that intact Selank reaches brain tissue in meaningful amounts is limited, and the extent of blood-brain barrier penetration is debated. Some authors argue that fragments, not the parent peptide, carry much of the observed activity.

Published clinical work is concentrated in Russian-language journals and generally involves small samples without independent replication. Systematic reviews in English note the shortage of randomised, placebo-controlled trials and the difficulty of verifying methods from translated reports. Outcome measures vary between studies, which complicates pooling of results. Interest in the compound as a cognitive or anxiolytic agent therefore rests on a thinner evidence base than the volume of citations suggests. Replication in well-powered trials with preregistered endpoints would be needed before firm conclusions about efficacy can be drawn.

Proposed mechanisms centre on the GABAergic system. Animal and tissue studies report changes in GABA-A receptor expression and reduced activity of GABA transaminase, the enzyme that degrades GABA. Effects on monoamine turnover, including serotonin and dopamine pathways, are also described, and a separate line of work links the peptide to increased expression of brain-derived neurotrophic factor in hippocampal tissue. Most of these findings come from rodent models and cell preparations. How the individual observations combine into a single coherent mode of action is not settled.

Peptide Identity and Structure

Selank is not a naturally occurring peptide and has no known endogenous counterpart in human physiology. Russian-language sources frequently call it TP-7, while English-language sources use the name Selank almost exclusively. Database indexing is uneven, partly because early reports appeared in regional journals that are not widely cataloged. Some summaries describe the material as a tuftsin analog and others as a synthetic heptapeptide; the labels overlap rather than conflict. Citing the primary sequence resolves ambiguity more reliably than the research or trade name alone.

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, written TKPRPGP in one-letter notation. Its structure consists of the immunomodulatory tetrapeptide tuftsin, Thr-Lys-Pro-Arg, extended at the carboxyl terminus by a Pro-Gly-Pro segment. The molecular formula is commonly given as C33H57N11O9, corresponding to a monoisotopic mass near 751.4 Da and an average molecular mass near 751.9 Da. All seven residues are proteinogenic amino acids, and the molecule carries no modified side chains or non-natural linkages.

Selank at a glance

PropertyValueNotes
Primary route studiedIntranasalAlso examined parenterally in animal work
Reported plasma half-lifeMinutes to tens of minutesValues vary widely between reports
Main model systemsRodent behavioural and cell assaysHuman trials are few and small
Principal proposed targetsGABA-A receptor, GABA transaminaseMonoamine and neurotrophic pathways also reported
Evidence gradePreliminaryLimited independent replication

Origins and Proposed Mechanisms

Published clinical evidence is limited. Most controlled trials were conducted in Russia, enrolled modest numbers of participants, and appeared in Russian-language journals, which restricts independent verification. Reported outcomes include lower anxiety scores, improved attention and memory measures, and changes in fatigue ratings. Reviews written in English note methodological limitations such as small samples and inconsistent endpoints. Whether the compound produces clinically meaningful benefit relative to established anxiolytics is therefore an open question rather than an established finding.

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was designed at the Institute of Molecular Genetics of the Russian Academy of Sciences as a structural analogue of tuftsin, a naturally occurring tetrapeptide fragment of the immunoglobulin heavy chain. The added Pro-Gly-Pro tail was intended to slow enzymatic degradation and extend biological activity. In Russia it is registered as an anxiolytic nasal preparation, while regulators elsewhere have not approved it for clinical use.

Related pages on this site

Selank Origin and Chemical Identity

The compound has a calculated molecular weight near 751.9 daltons and carries a net positive charge at physiological pH because of its arginine residue. It dissolves freely in water and in common aqueous buffers, and typically appears as a white or off-white lyophilized powder. The amide backbone makes the molecule susceptible to peptidases, which limits oral use and favors intranasal or parenteral routes. Nomenclature in the literature varies: the substance is also described by the sequence abbreviation TP-7 and by a Russian trade designation.

Regulatory status differs sharply by region. Selank holds a Russian marketing authorization, where it is supplied mainly as nasal drops, while authorities elsewhere have not approved it for medical use. Material sold internationally is therefore usually labeled as a research chemical rather than a medicine. Peer-reviewed publications come predominantly from Russian laboratories, and sample sizes are generally small. Whether the compound produces comparable effects under independent, well-controlled replication remains an open question that the broader literature has not settled.

Selank is a synthetic heptapeptide developed in Russia as a structural analogue of tuftsin, a naturally occurring immunomodulatory tetrapeptide. Its sequence, Thr-Lys-Pro-Arg-Pro-Gly-Pro, keeps the tuftsin core at the N-terminus and appends a Pro-Gly-Pro tail. Researchers at the Institute of Molecular Genetics in Moscow synthesized the compound during the 1990s while searching for peptides with combined anxiolytic and immunomodulatory activity. The added tail was intended to resist enzymatic cleavage and prolong the molecule's presence in circulation.

Background and Peptide Identity

Tuftsin, the parent structure, is a naturally occurring immunomodulatory tetrapeptide released from the Fc region of immunoglobulin G by spleen enzymes. Selank extends this four-residue sequence with three additional amino acids. The stated rationale is that the added tail slows enzymatic breakdown and may influence receptor interactions. How the full heptapeptide behaves at the molecular level is not firmly established, and proposed mechanisms often involve indirect modulation of neurotransmitter or immune signaling rather than a single defined target.

Selank is a synthetic heptapeptide developed in Russia. Its sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, a seven-residue chain built around the natural tetrapeptide tuftsin. Researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences first described the compound in the mid-1990s. The design combined the tuftsin core with an added Pro-Gly-Pro tail, a modification intended to extend the molecule's stability in biological fluids. Published work on the peptide has appeared mainly in Russian-language journals.

Selank Handling, Stability, and Analysis

Once dissolved, the peptide is markedly less stable than the dry powder. Aqueous solutions are subject to backbone hydrolysis and to microbial growth when they are handled without sterile technique. Buffered solutions near neutral pH are common for short-term laboratory work, while acidic conditions are sometimes used to improve solubility. Analytical laboratories generally prepare working solutions fresh rather than storing them, and a residual water film left in a reopened vial can seed degradation even when the container appears dry.

Reversed-phase high-performance liquid chromatography is the standard technique for estimating peptide purity. The result is a peak-area percentage, which describes how much of the detected material elutes as the main peak in one run. Mass spectrometry confirms the molecular mass and can reveal truncated, adducted, or otherwise modified species. Amino acid analysis or tandem mass spectrometry can address sequence fidelity when identity is in doubt. None of these measurements, taken alone, establishes that a sample is fit for any specific purpose.

Reference notes

deliquescence A substance's affinity for water, often characterized as its tendency to absorb moisture from the atmosphere to form aqueous solutions. Most strongly deliquescent substances are salts, such as calcium chloride and potassium carbonate.

Founder, Professionals with Alzheimer's. For services to Charity. Kenneth Salter. For services to the community in Ellesmere Port, Cheshire. Cheryl Anne Sanderson. For services to Cancer Patients in Barnsley, South Yorkshire. David Saunders. For services to the community in Middlesbrough, North Yorkshire. Annie Groat Scott. For services to the community in Westray, Orkney. Pamela Mary Joyce Scull (Pamela Wingfield). Founder Principal, Wingfield School of Ballet and Dance. For services to Dance and to the community in Bristol. Sanjay Shambhu. Councillor, South Gloucestershire Council and Chair, BAME Conservatives. For Political Service. John Frederick Sharman. For services to the community in Peterborough, Cambridgeshire. Janice Sheward. Director, Cancer United. For services to People with Cancer in West Sussex. Darren Keith Sims. Founder, Daz's Rock 4 Charity. For Charitable Fundraising for Disabled and Disadvantaged Young People. Ian Robert Skinner. For services to the community in Sidmouth and the Sid Valley, Devon. Angela Ann Smith. Lately Deputy Manager, Process Controls Team, Defence Business Services. For services to Defence and to Charity. Carl Smith. Advanced Paramedic in Critical Care, East of England Ambulance Service NHS Trust, Head, Clinical Development for Emergency and Critical Care, College of Paramedics and Firefighter, Norfolk Fire and Rescue Service. For services to the NHS and to Fire and Rescue. Cheryl Barbara Smith. Leader, Girlguiding Cornwall. For services to Young People. John Alexander Alister Smyth.

=== Cultures === Samples undergoing examination for pathogens, primarily in medical microbiology, may be incubated with culture media. Those allow, for example, the description of one or several infectious agents responsible of the clinical signs.

Pindolol, sold under the brand name Visken among others, is a non-selective beta blocker which is used in the treatment of hypertension. It is also an antagonist of the serotonin 5-HT1A receptor, preferentially blocking inhibitory 5-HT1A autoreceptors, and has been researched as an add-on therapy to various antidepressants, such as clomipramine and the selective serotonin reuptake inhibitors (SSRIs), in the treatment of depression and obsessive–compulsive disorder (OCD).

The compound is now under active investigation by researchers at NIMH for potential clinical use, and it is hoped that use of HNK instead will mitigate the various concerns (such as abuse and dissociation) of using ketamine itself in the treatment of depression.

Sources: en.wikipedia.org

Notes from published material

== Science and technology == MSI Barcode, a continuous numeric barcode symbology Microsatellite instability, an abnormality of DNA Mass spectrometry imaging, a technique used in mass spectrometry Mass sociogenic illness, the rapid spread of physical symptoms of illness among the members of a group with no physical or infectious cause Magnetic source imaging, magnetoencephalography combined with magnetic resonance imaging Multispectral imaging, the capture of multiple, specific wavelengths in the electromagnetic spectrum Musculoskeletal injury, damage of muscular or skeletal systems which is usually due to a strenuous activity

=== Religion === Latter Day Saint movement (LDS movement), a collection of independent church groups The Church of Jesus Christ of Latter-day Saints, the largest group within the Latter Day Saint movement Latvijas Dievturu Sadraudze, a Latvian neopagan organization

===== Hydrogen adsorption enthalpy ===== High hydrogen adsorption enthalpy is also important. Theoretical studies have shown that 22–25 kJ/mol interactions are ideal for hydrogen storage at room temperature, as they are strong enough to adsorb H2, but weak enough to allow for quick desorption. The interaction between hydrogen and uncharged organic linkers is not this strong, and so a considerable amount of work has gone in synthesis of MOFs with exposed metal sites, to which hydrogen adsorbs with an enthalpy of 5–10 kJ/mol. Synthetically, this may be achieved by using ligands whose geometries prevent the metal from being fully coordinated, by removing volatile metal-bound solvent molecules over the course of synthesis, and by post-synthetic impregnation with additional metal cations. (C5H5)V(CO)3(H2) and Mo(CO)5(H2) are great examples of increased binding energy due to open metal coordination sites; however, their high metal-hydrogen bond dissociation energies result in a tremendous release of heat upon loading with hydrogen, which is not favorable for fuel cells. MOFs, therefore, should avoid orbital interactions that lead to such strong metal-hydrogen bonds and employ simple charge-induced dipole interactions, as demonstrated in Mn3[(Mn4Cl)3(btt)8]2. An association energy of 22–25 kJ/mol is typical of charge-induced dipole interactions, and so there is interest in the use of charged linkers and metals.

==== Opening reception at Havana Auditorium ==== At 8:30pm on Saturday, February 26, an evening reception was held at the Havana Auditorium in Vedado, with an opening keynote speech from Grand Master Carlos M. Piñeiro del Cueto. Civil and military authorities of the Republic of Cuba also sat at the head of the reception. Grand Master Piñeiro expressed: "...the profound emotion, the sincere feeling that Cuban Freemasonry... is experiencing at this moment for having gathered so many fraternal values into a solid and tightly knit bundle." A colour guard from the Boy Scouts of Cuba carried the flags of each country represented at the conference and planted them on the stage. The Grand Master's own daughter, Luisa María Piñeiro y Cresno, carried the flag of the CMI. Alfonso Poletti then spoke on behalf of the Mexican delegation. Charles Mantz, Grand Master of the Grand Lodge of Colorado, spoke on behalf of the United States and the Conference of Grand Masters of North America.

== Research == Stem cell therapy may represent a treatment for promoting the healing of diabetic foot ulcers. Diabetic foot ulcers develop their own, distinctive microbiota. Investigations into characterizing and identifying the phyla, genera, and species of nonpathogenic bacteria or other microorganisms populating these ulcers may help identify one group of microbiota that promotes healing. The recent advances in epigenetic modifications, with special focus on aberrant macrophage polarisation, are giving increasing evidence that epigenetic modifications might play a vital role in changing the treatment of diabetic foot ulcer in the near future.

Sources: en.wikipedia.org

Frequently asked questions

What mechanisms are proposed for Selank?

Reports describe modulation of GABA signalling, changes in monoamine turnover and effects on neurotrophic factor expression. These observations come mainly from animal and cell studies. A single unifying mechanism has not been demonstrated.

What happens to Selank after intranasal dosing?

The peptide enters plasma rapidly and is broken down by ordinary proteases into amino acids and shorter fragments. Reported half-lives are short. Whether meaningful amounts of the intact molecule reach the brain is an open question.

How strong is the clinical evidence?

Most clinical reports are small, published in Russian and not independently replicated. English-language reviews highlight the absence of large randomised trials. Conclusions about efficacy should be treated as provisional.

What is the primary sequence of Selank?

The sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, written TKPRPGP in one-letter code. It combines the tetrapeptide tuftsin with a carboxyl-terminal Pro-Gly-Pro extension. This full sequence identifies the molecule more precisely than the research name.

Network